Abbott, Other Formula Makers Face FTC Investigation For Collusion - WSJ | Old North State Wealth News
Connect with us


Abbott, other formula makers face FTC investigation for collusion – WSJ



(Reuters) -The U.S. Federal Trade Commission is investigating whether baby-formula makers colluded on bids for attractive state contracts, the Wall Street Journal reported on Wednesday.

The FTC is looking into whether Abbott Laboratories (NYSE:) and other formula manufacturers have “engaged in collusion or coordination with any other market participant regarding the bidding”, the WSJ report said, citing documents posted to FTC’s website.

The Journal added that the antitrust agency is also investigating whether company coordination affected sales more broadly, outside of the Women, Infants and Children (WIC) formula-supply program.

The FTC has sought information from Nestle, which makes the Good Start line of infant formulas, a company spokeswoman told the Journal, adding that the Swiss manufacturer has responded to the FTC.

FTC, Abbott, and Nestle did not immediately respond to Reuters requests for comment.

In February, Abbott said it received a civil investigative demand from the FTC related to a probe of the companies participating in bids for WIC formula contracts.

Read the full article here


Copyright © 2022 ONSWM News. Content posted on the Old North State Wealth News page was developed and produced by a third party news aggregation service. Old North State Wealth Management is not affiliated with the news aggregation service. The information presented is believed to be current. It should not be viewed as personalized investment advice. All expressions of opinion reflect the judgment of the authors on the date the articles were published. The information presented is not an offer to buy or sell, or a solicitation of any offer to buy or sell, any of the securities discussed.